Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)

Tip Ranks
2025.11.07 16:16
portai
I'm PortAI, I can summarize articles.

Lake Street analyst Thomas Flaten has reaffirmed a Buy rating on Achieve Life Sciences (ACHV) with a price target of $11.00. Flaten, a 5-star analyst with an 18.0% average return and a 54.15% success rate, focuses on the Healthcare sector. The current analyst consensus for Achieve Life Sciences is a Strong Buy, with an average price target of $14.60.

Lake Street analyst Thomas Flaten maintained a Buy rating on Achieve Life Sciences today and set a price target of $11.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Flaten is a 5-star analyst with an average return of 18.0% and a 54.15% success rate. Flaten covers the Healthcare sector, focusing on stocks such as Achieve Life Sciences, Insight Molecular Diagnostics, and Harrow Health.

Currently, the analyst consensus on Achieve Life Sciences is a Strong Buy with an average price target of $14.60.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer